COVID: Mild cases at risk of deterioration to be given antibody drug
Regeneron was authorized in November for emergency use by the US Food and Drug Administration (FDA).
The Regeneron Pharmaceuticals company logo is seen on a building at the company's Westchester campus in Tarrytown, New York, US September 17, 2020.(photo credit: BRENDAN MCDERMID/REUTERS)ByROSSELLA TERCATIN
